Healio

Interleukin-23 inhibitors exhibit lowest paradoxical eczema risk in psoriasis treatment

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. IL-23 inhibitors were associated with the lowest ...
Healio

Positive results showcase icotrokinra’s ‘unique’ mechanism of action in plaque psoriasis

Please provide your email address to receive an email when new articles are posted on . Late-breaking data supported the efficacy of icotrokinra, an interleukin-23 inhibitor, for plaque psoriasis. By ...
MedPage Today

Can an Autoimmunity Lead to Immune Deficiency?

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window People mounting ...
clinicaladvisor.com

Interleukin-23 Inhibitors Linked to Lower Risk for Eczema in Patients With Psoriasis

Researchers determine the clinical and demographic risk factors of paradoxical eczema as well as the overall incidence and biologic-class-specific risk factors and incidence of paradoxical eczema in ...
Seeking Alpha

Protagonist Reports Positive Results from Phase 1 and Pre-clinical Studies of Oral Interleukin-23 Receptor Antagonist JNJ-2113

Data point to the potential of JNJ-2113 as a first-in-class drug candidate in multiple IL-23 driven-diseases Highlights of the data presented on JNJ-2113 include the following: JNJ-2113 is a ...